首页> 美国政府科技报告 >Noncovalent Complex Vaccine, Prepared with Detoxified Escherichia coli J5 (RcChemotype) Lipopolysaccharide and Neisseria meningitidis Group B Outer Membrane Protein, Produces Protective Antibodies against Gram-Negative Bacteremia
【24h】

Noncovalent Complex Vaccine, Prepared with Detoxified Escherichia coli J5 (RcChemotype) Lipopolysaccharide and Neisseria meningitidis Group B Outer Membrane Protein, Produces Protective Antibodies against Gram-Negative Bacteremia

机译:非共价复合疫苗,用解毒的大肠杆菌J5(RcChemotype)脂多糖和脑膜炎奈瑟菌B组外膜蛋白制备,产生针对革兰氏阴性菌血症的保护性抗体

获取原文

摘要

Earlier studies showed that purified IgG from sera of rabbits immunized with aboiled Escherichia coli J5 (Rc chemotype) whole cell vaccine protected neutropenic rats against gram-negative bacterial sepsis. In the present study, de-O-acylated J5 lipopolysaccharide (J5 DLPS) as a noncovalent complex with Neisseria meningitidis group B outer membrane protein (GBOMP) elicited anti-J5 LPS antibodies in rabbits. IgG prepared from immune rabbit sera protected neutropenic rats against lethal challenge with Pseudomonas aeruqinosa 12:4:4. Sixteen of 26 rats treated with the postimmune serum IgO were protected compared with none of 20 rats treated with the control rabbit serum IgO (p < .001). In vitro binding studies showed binding of anti-J5 IgG to several gram-negative bacteria. These results indicate that a subunit vaccine made of J5 DLPS as a non-covalent complex with GEOMP may protect against gram-negative bacteremia.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号